Hata Y, Uchino J, Sasaki F, Koike Y, Takada N, Alam S, Morita Y
First Department of Surgery, Hokkaido University Hospital, Sapporo, Japan.
J Pediatr Surg. 1989 Apr;24(4):382-5. doi: 10.1016/s0022-3468(89)80276-3.
The possibility of kidney-preserving radical tumor resection in advanced neuroblastoma was evaluated. Eighteen patients with stage III and IV adrenal neuroblastoma underwent delayed primary surgery after chemotherapy consisting of high doses of cyclophosphamide (1,250 mg/m2). Radical tumor resection with nephrectomy was performed in 13 patients (group A) and kidney-preserving radical tumor resection was performed in six patients (group B). Macroscopic findings were evaluated in all patients; angiographic and microscopic findings were evaluated in group A patients and tumor recurrence in group B patients. Macroscopically, the tumors were observed within the tumor capsule (C1) in five, outside the tumor capsule but not beyond the midline (C2) in seven, and beyond the midline (C3) in six. In group A, under microscopic examination, the tumor invasion into the renal parenchyma was observed in only three patients among C2 and C3 cases. Tumor vessels from the capsular and/or perforating arteries plus from the intrarenal arteries could be visualized in all patients, three of whom had tumor invasion into the renal parenchyma. In group B, no tumor recurrence around the kidney occurred, and two patients have survived for greater than 2 years. The kidney-preserving radical tumor resection is recommended in surgical treatment of advanced neuroblastoma following preoperative chemotherapy, and is predictable preoperatively by angiography.
评估了晚期神经母细胞瘤保留肾的根治性肿瘤切除术的可能性。18例III期和IV期肾上腺神经母细胞瘤患者在接受由高剂量环磷酰胺(1250mg/m²)组成的化疗后接受了延迟一期手术。13例患者(A组)进行了根治性肿瘤切除并肾切除术,6例患者(B组)进行了保留肾的根治性肿瘤切除术。对所有患者的宏观表现进行了评估;对A组患者的血管造影和微观表现以及B组患者的肿瘤复发情况进行了评估。宏观上,5例患者的肿瘤位于肿瘤包膜内(C1),7例患者的肿瘤位于肿瘤包膜外但未超过中线(C2),6例患者的肿瘤超过中线(C3)。在A组中,显微镜检查发现,在C2和C3病例中只有3例患者的肿瘤侵犯了肾实质。所有患者均可观察到来自包膜和/或穿支动脉以及肾内动脉的肿瘤血管,其中3例患者的肿瘤侵犯了肾实质。在B组中,肾周未发生肿瘤复发,2例患者存活超过2年。对于晚期神经母细胞瘤术前化疗后的手术治疗,建议进行保留肾的根治性肿瘤切除术,并且术前通过血管造影可预测。